Consolidated Statement of
Cash Flows (IFRS) – unaudited

For the Period Ended March 31,

Note 2009 2008
Operating Activities
Net Profit 3,506,848 3,264,547
Adjustments to Reconcile Net Profit to Net Cash Used in/Provided by Operating Activities:
Non-cash Charges from PPA 0 14,125
Depreciation and Amortization of Tangible and Intangible Assets 1,279,863 1,303,008
Income Tax Benefit (41,734) (59,664)
Net Gain on Sales of Financial Assets (771,555) (406,285)
Unrealized Net Loss/(Gain) on Derivative Financial Instruments 103,016 (136,938)
(Gain) / Loss on Sale of Property, Plant and Equipment (497) 238
Recognition of Deferred Revenue (7,998,800) (7,899,478)
Stock-based Compensation 282,136 293,148
Changes in Operating Assets and Liabilities:
Accounts Receivable (1,554,658) 2,124,512
Prepaid Expenses, Other Assets and Tax Receivables 1,305,065 (906,196)
Accounts Payable and Provisions 1,518,484 732,303
Licenses Payable 2,110,793 5,450
Other Liabilities (2,831,794) (5,867,573)
Deferred Revenue 1,163,314 11,661,816
Cash Generated from Operations (1,929,519) 4,123,013
Interest Paid 0 0
Interest Received (136,405) (361,270)
Income Taxes Paid 395,476 191,463
Net Cash Used in/Provided by Operating Activities (1,670,448) 3,953,206

See accompanying notes to the Interim Consolidated Financial Statements

For the Period Ended March 31,

Note 2009 2008
Investing Activities:
Purchases of Financial Assets 0 (22,789,616)
Proceeds from Sales of Financial Assets 7,345,773 5,210,739
Purchases of Property, Plant and Equipment (159,873) (238,667)
Proceeds from Disposals of Property, Plant and Equipment 530 0
Additions to Intangibles (131,281) (90,549)
Net Cash Provided by/ Used in Investing Activities 7,055,149 (17,908,093)
 
Financing Activities:
Proceeds from the Exercise of Options and Convertible Bonds Granted to Related Parties 61,155 299,946
Net of Proceeds and Payments from the Issuance of Convertible Bonds Granted to Related Parties (1,850) 0
Purchases of Derivative Financial Instruments (173,304) (75,000)
Proceeds from the Disposal of Derivative Financial Instruments 47,000 170,359
Net Cash Used in/ Provided by Financing Activities (66,999) 395,305
 
Effect of Exchange Rate Differences on Cash (17,862) 114,422
Increase / (Decrease) in Cash and Cash Equivalents 5,299,840 (13,445,160)
Cash and Cash Equivalents at the Beginning of the Period 40,113,727 48,407,064
Cash and Cash Equivalents at the End of the Period 45,413,567 34,961,904

See accompanying notes to the Interim Consolidated Financial Statements